Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
News releases from Pfizer Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
March 07, 2018
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology, and Chris Boshoff, Senior Vice President and Head,...
Tickers
PFE
From
Business Wire News Releases
Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression
September 13, 2016
Today, Pfizer Inc announced it has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health...
Tickers
PFE
From
Business Wire News Releases
Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
June 11, 2015
Tickers
PFE
From
Business Wire News Releases
Spiriva® HandiHaler® (tiotropium bromide inhalation powder) and COPD Data to be Presented at the 2012 European Respiratory Society (ERS) Congress
August 31, 2012
Tickers
PFE
From
Business Wire News Releases
Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions
June 20, 2012
Tickers
PFE
From
Business Wire News Releases
Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)
May 15, 2012
Tickers
PFE
From
Business Wire News Releases
Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older
July 29, 2011
Tickers
PFE
From
Business Wire News Releases
Pfizer Inc and Progenics Alert Physicians and Patients to Information Related to Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging
January 25, 2011
Tickers
PFE
PGNX
From
Business Wire News Releases
FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
November 20, 2009
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations
Tickers
PFE
From
Business Wire News Releases
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
November 19, 2009
Advisory Committee Also Reaffirms the Product’s Safety Profile
Tickers
PFE
From
Business Wire News Releases
Pfizer Encourages Families To Bring Their Dogs To This Year’s Holiday Celebration
November 19, 2009
Tickers
PFE
From
Business Wire News Releases
FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
November 18, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases
November 18, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)
November 17, 2009
Filing Follows EMEA’s Conclusion that Pfizer’s Program Studying the Use of Lipitor in Children with High Cholesterol is in Compliance with its Requirements
Tickers
PFE
From
Business Wire News Releases
Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo
November 04, 2009
Findings from Pfizer-Sponsored Study Presented as Late-Breaker at American College of Chest Physicians Annual Meeting
Tickers
PFE
From
Business Wire News Releases
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease
November 03, 2009
International Studies to Evaluate Effects of Dimebon in Combination Therapy: One in Patients on Background Donepezil, One in Patients on Background Memantine
Tickers
MDVN
PFE
From
Business Wire News Releases
Pfizer Completes Consent Solicitation
October 30, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation
October 29, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend
October 22, 2009
Tickers
PFE
From
Business Wire News Releases
New Pfizer Animal Health is Unveiled with Acquisition of Wyeth
October 19, 2009
Addition of Fort Dodge Animal Health Products Diversifies and Enhances Pfizer’s Already Robust U.S. Portfolio
Tickers
PFE
From
Business Wire News Releases
CP-690,550, Pfizer’s Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis
October 17, 2009
Final Phase 2 Analyses Presented at the American College of Rheumatology/ Association of Rheumatology Health Professionals (ACR/ARHP) Annual Scientific Meeting
Tickers
PFE
From
Business Wire News Releases
Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture
October 16, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer And Wyeth Become One: Working Together For A Healthier World™
October 15, 2009
Added Capabilities, Assets and Talent Advance Pfizer’s Mission to Apply Science and Global Resources to Improve Health and Well Being at Every Stage of Life
Tickers
PFE
From
Business Wire News Releases
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
October 14, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend®
October 14, 2009
Tickers
PFE
From
Business Wire News Releases
FDA Advisory Committee Recommends Approval of Pfizer’s Selzentry for Use in Patients Starting HIV Therapy for the First Time
October 08, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth
September 29, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer Receives Approval from China’s Ministry of Commerce for Pending Wyeth Acquisition
September 29, 2009
Tickers
PFE
From
Business Wire News Releases
Frances D. Fergusson And John P. Mascotte Elected To Pfizer’s Board Of Directors
September 25, 2009
Tickers
PFE
From
Business Wire News Releases
Pfizer and Eisai Continue Aricept Collaboration
September 24, 2009
Companies also enter into new collaboration to co-promote Lyrica in Japan
Tickers
PFE
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.